EC Number   |
Inhibitors |
Structure |
|---|
    3.3.2.10 | (1R,2R)-1,2-epoxy-1-phenyl-1-propane |
weak inhibition, IC50 is 1.1 mM |
   |
| 3.3.2.10 | (1R,2R,4R,5S,6R,7S)-4-[(benzyloxy)methyl]-3,8-dioxatricyclo[5.1.0.02,4]octane-5,6-diyl diacetate |
5.87% inhibition |
|
| 3.3.2.10 | (1R,3S)-N-(4-cyano-2-(trifluoromethyl)benzyl)-3-((4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)amino)cyclohexanecarboxamide |
GSK2256294 |
|
| 3.3.2.10 | (1S,2S)-1,2-epoxy-1-phenyl-1-propane |
weak inhibition, IC50 is 2.4 mM, preincubation of enzyme with inhibitor does not influence the inhibitory effect |
|
| 3.3.2.10 | (1S,3R)-N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]cyclohexane-1-carboxamide |
GSK2256294 |
|
| 3.3.2.10 | (1S,6S,9R)-1-(4-hydroxy-3-methoxyphenyl)-6-methoxy-9-methyl-4-(prop-2-en-1-yl)-7-oxabicyclo[4.2.1]non-4-ene-3,8-dione |
75.56% inhibition |
|
| 3.3.2.10 | (1Z)-1-[(4aS,8aR)-2-(3-[[(2S)-2-(5-methylfuran-2-yl)-2-(pyrrolidin-1-yl)ethyl]carbamoyl]phenyl)-4-oxooctahydrophthalazin-1(2H)-ylidene]dioxidan-1-ium |
- |
|
| 3.3.2.10 | (2E)-4-[(2-methylpropyl)amino]-4-oxobut-2-enoic acid |
25.86% inhibition |
|
| 3.3.2.10 | (2E)-5-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)pent-2-enamide |
93.12% inhibition, uncompetitive inhibition |
|
| 3.3.2.10 | (2E,4E)-5-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)penta-2,4-dienamide |
86.54% inhibition, uncompetitive inhibition |
|
